ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE
This analytic paper presents the evidence on the potential of acetylsalicylic acid (ASA) for the mortality reduction in patients with cardiovascular disease. The focus is on the “minimal” effective dose of ASA, in terms of its effects on survival. The discussion of the ASA form and dose selection al...
Saved in:
| Main Author: | O. V. Averkov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2012-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1255 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01) -
Elevated Platelet‐to‐Lymphocyte Ratio as a Predictor of All‐Cause and Cardiovascular Mortality in Hypertensive Individuals
by: Rui Xu, et al.
Published: (2025-01-01) -
Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk
by: F. I. Belyalov, et al.
Published: (2016-09-01) -
Association of glucose to lymphocyte ratio with the risk of death in patients with atherosclerotic cardiovascular disease
by: Jinglin Lei, et al.
Published: (2025-01-01) -
Endothelial Activation and Stress Index Predicts All‐Cause and Cardiovascular Mortality in Hypertensive Individuals: A Nationwide Study
by: Gaiying Dong, et al.
Published: (2025-04-01)